11.96
price up icon11.57%   1.24
after-market After Hours: 11.92 -0.04 -0.33%
loading
Scilex Holding Company stock is traded at $11.96, with a volume of 240.85K. It is up +11.57% in the last 24 hours and up +122.30% over the past month. Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
See More
Previous Close:
$10.72
Open:
$10.88
24h Volume:
240.85K
Relative Volume:
1.59
Market Cap:
$83.14M
Revenue:
$46.74M
Net Income/Loss:
$-114.33M
P/E Ratio:
-9.2713
EPS:
-1.29
Net Cash Flow:
$-21.04M
1W Performance:
+34.99%
1M Performance:
+122.30%
6M Performance:
-22.41%
1Y Performance:
-79.90%
1-Day Range:
Value
$10.14
$11.98
1-Week Range:
Value
$7.975
$12.41
52-Week Range:
Value
$3.60
$59.85

Scilex Holding Company Stock (SCLX) Company Profile

Name
Name
Scilex Holding Company
Name
Phone
(650) 516-4310
Name
Address
960 SAN ANTONIO ROAD, PALO ALTO
Name
Employee
111
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SCLX's Discussions on Twitter

Compare SCLX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
SCLX
Scilex Holding Company
11.96 58.89M 46.74M -114.33M -21.04M -1.29
Drug Manufacturers - General icon
LLY
Lilly Eli Co
812.69 723.06B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
168.30 407.97B 90.63B 22.66B 16.40B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
190.28 337.08B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
117.70 227.39B 55.19B 13.65B 16.81B 6.86
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
71.70 314.28B 43.59B 15.04B 10.74B 3.3766

Scilex Holding Company Stock (SCLX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-27-25 Initiated D. Boral Capital Buy
Oct-16-24 Initiated Alliance Global Partners Buy
Jun-13-24 Initiated Rodman & Renshaw Buy
Oct-16-23 Initiated B. Riley Securities Buy
Oct-13-23 Initiated B. Riley Securities Buy
Oct-09-23 Initiated H.C. Wainwright Buy
View All

Scilex Holding Company Stock (SCLX) Latest News

pulisher
Jul 25, 2025

What analysts say about Scilex Holding Company Equity Warrant stockGame-changing returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Scilex Holding Company Equity Warrant a good long term investmentConsistent double returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Will Scilex Holding Company stock benefit from interest rate changesRapidly growing investment returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Scilex Holding Company Stock Analysis and ForecastRapid market gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Scilex Holding Company Equity Warrant stock priceOverwhelming financial success - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Scilex’s Semnur Amends Merger Agreement with Denali - The Globe and Mail

Jul 24, 2025
pulisher
Jul 23, 2025

Oramed Pharm and Scilex Finalize Option Agreement - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Scilex Holding amends merger agreement with Denali Capital Acquisition - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Scilex Holding amends merger agreement with Denali Capital Acquisition By Investing.com - Investing.com UK

Jul 23, 2025
pulisher
Jul 23, 2025

Scilex Holding’s New Stock Purchase Agreement with Tumim - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Scilex Holding Company: Merger Agreement Amended, Adds Russell Indexes, Reports Earnings, and Announces FDA Approval - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Scilex Holding Company stock priceMarket-crushing profits - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Scilex Holding Company Equity Warrant Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Scilex Holding Company stockExtraordinary profit generation - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-23 00:12:24 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Scilex Holding Company a good long term investmentMarket-crushing stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Is Scilex Holding Company Equity Warrant stock a growth or value playFree Stock Market Knowledge Sharing - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

What institutions are buying Scilex Holding Company Equity Warrant stock nowCapital Safe Smart Trades - Newser

Jul 18, 2025

Scilex Holding Company Stock (SCLX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Scilex Holding Company Stock (SCLX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Ji Henry
Executive Chairperson
Oct 31 '24
Buy
0.94
8,888
8,351
320,161
SHAH JAISIM
See Remarks
Oct 29 '24
Buy
0.99
32,000
31,670
109,333
Followwill Dorman
Director
Oct 18 '24
Buy
0.99
1,000
990
2,300
Chun Jay
Director
Oct 18 '24
Buy
0.95
5,000
4,750
112,500
Wu Yue Alexander
Director
Oct 17 '24
Buy
0.95
20,000
18,992
25,000
Lemus David
Director
Oct 17 '24
Buy
0.90
2,000
1,800
2,000
Ji Henry
Executive Chairperson
Oct 17 '24
Buy
0.97
10,000
9,710
60,070
SHAH JAISIM
See Remarks
Oct 16 '24
Buy
0.99
30,000
29,751
77,333
Ma Stephen Hoi
Chief Financial Officer
Oct 16 '24
Buy
0.97
6,700
6,499
22,840
drug_manufacturers_general SNY
$50.37
price up icon 0.48%
drug_manufacturers_general PFE
$24.79
price down icon 2.21%
$116.20
price up icon 2.65%
$306.58
price down icon 0.64%
drug_manufacturers_general MRK
$84.71
price up icon 0.71%
drug_manufacturers_general NVO
$71.70
price up icon 1.37%
Cap:     |  Volume (24h):